Vir Biotechnology Announces New Research Demonstrating Novel Mechanisms by Which SARS-CoV-2 Enters Host Cells

NEXT STORY
Ocuphire Initiates ZETA-1 Phase 2 Clinical Trial Investigating APX3330 in Diabetic Retinopathy
PREV STORY
Cell Culture Market Size to Reach USD 45.12 Billion in 2027 | Rising Demand for Monoclonal Antibodies, Growing Preference for Customized Therapies are Some Major Factors Driving Industry Growth, says Emergen Research
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Helsinn Group Announces European Medicines Agency’s (EMA) Acceptance for review of the Marketing Authorization Application (MAA) for Infigratinib for Patients with Cholangiocarcinoma with Fibroblast Growth Factor Receptor 2 Fusions or Rearr

author_avatar
NASDAQ Market News

Dextera Surgical’s MicroCutter Technology Highlighted at Annual Meeting of the German Society for Thoracic Surgery

FREIBURG, Germany, Sept. 27, 2016 (GLOBE NEWSWIRE) -- Dextera Surgical Inc. (Nasdaq:DXTR), manufacturer of ...

author_avatar
NASDAQ Market News

Hua Medicine’s Pivotal Phase III Monotherapy Trial of Dorzagliatin, a Dual-Acting Glucokinase Modulator, Achieves Primary Efficacy Endpoint in Patients with Type 2 Diabetes

author_avatar
NASDAQ Market News